Jump to content

Paraoxonase

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Jls043 (talk | contribs) at 10:36, 20 July 2013. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

paraoxonase 1
Identifiers
SymbolPON1
Alt. symbolsPON
NCBI gene5444
HGNC9204
OMIM168820
RefSeqNM_000446
UniProtP27169
Other data
EC number3.1.8.1
LocusChr. 7 q21.3
Search for
StructuresSwiss-model
DomainsInterPro
paraoxonase 2
Identifiers
SymbolPON2
NCBI gene5445
HGNC9205
OMIM602447
RefSeqNM_000305
UniProtQ15165
Other data
EC number3.1.8.1
LocusChr. 7 q21.3
Search for
StructuresSwiss-model
DomainsInterPro
paraoxonase 3
Identifiers
SymbolPON3
NCBI gene5446
HGNC9206
OMIM602720
RefSeqNM_000940
UniProtQ15166
Other data
EC number3.1.8.1
LocusChr. 7 q21.3
Search for
StructuresSwiss-model
DomainsInterPro

Paraoxonases are a group of enzymes involved in the hydrolysis of organophosphates.[1]

History

PON was identified as an enzyme having organophosphates as its substrates. Reports of the geographic differences in population frequencies of paraoxonase activity and genetic analysis led to uncovering the genetic polymorphism.

Types

There are 3 known genotypic forms of paraoxonases. They are coded for by the PON set of genes – PON1, PON2 and PON3 – located on the long arm of chromosome 7.[2][3] The differences between them lie in their location and activity.

  • PON1 is synthesized in the liver and transported along with HDL in the plasma. It functions as an antioxidant; it prevents the oxidation of LDL. Its serum concentration is influenced by inflammatory changes and the levels of serum oxidised-LDL.
  • PON3 is similar to PON1 in activity but differs from it in substrate specificity. Additionally, it is not regulated by inflammation and levels of oxidised lipids.[5]

Clinical Significance

PON1 and PON3 are implicated in lowering the risk of developing coronary artery disease and atherosclerosis. PON1 and PON3 prevent the formation of atherogenic oxidised-LDL, the form of LDL present in foam cells of an atheromatous plaque.

3D Structure

The 3D structure of PON1 was determine in 1994 PON1 [6], see Proteopedia Paraoxonase.

References

  1. ^ La Du BN (1992). "Human serum paraoxonase/arylesterase". In Kalow W, editor (ed.). Pharmacogenetics of drug metabolism. New York: Pergamon Press. pp. pages 51–91. ISBN 0-08-041175-4. {{cite book}}: |editor= has generic name (help); |pages= has extra text (help)
  2. ^ Bergmeier C, Siekmeier R, Gross W (2004). "Distribution spectrum of paraoxonase activity in HDL fractions". Clin. Chem. 50 (12): 2309–15. doi:10.1373/clinchem.2004.034439. PMID 15459089. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  3. ^ Li HL, Liu DP, Liang CC (2003). "Paraoxonase gene polymorphisms, oxidative stress, and diseases". JOURNAL OF MOLECULAR MEDICINE. 81 (12): 766–779. PMID 14551701.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Ng CJ; Wadleigh DJ; Gangopadhyay A; et al. (2001). "Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein". J. Biol. Chem. 276 (48): 44444–9. doi:10.1074/jbc.M105660200. PMID 11579088. {{cite journal}}: Unknown parameter |author-separator= ignored (help); Unknown parameter |month= ignored (help)CS1 maint: unflagged free DOI (link)
  5. ^ Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM (2001). "Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids". Arterioscler. Thromb. Vasc. Biol. 21 (4): 542–7. doi:10.1161/01.ATV.21.4.542. PMID 11304470. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  6. ^ Harel, M. Aharoni, A, Gaidukov, L, Brumshtein, B, Khersonsky, O, Meged, R, Dvir, H, Ravelli, RB, McCarthy, A, Toker, L, Silman, I, Sussman, JL, Tawfik, DS (2004). "Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes". Nature Structural & Molecul. Biol. 11 (8): 412–9. PMID 15098021. {{cite journal}}: Unknown parameter |month= ignored (help); line feed character in |author= at position 10 (help)CS1 maint: multiple names: authors list (link)